Suchergebnisse - "Alberti, Paola"

PubPharm (7)

1

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2018

von Alberti, P. | Rossi, E. | Argyriou, A. | +10

2

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve

enthalten in: Supportive care in cancer | 2018

von Alberti, P. | Rossi, E. | Argyriou, A. | +10

3

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve

enthalten in: Supportive care in cancer | 2018

von Alberti, P. | Rossi, E. | Argyriou, A. | +10

4

Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve

enthalten in: Supportive care in cancer | 2018

von Alberti, P. | Rossi, E. | Argyriou, A. | +10

5

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy : A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2018

von Bruna, J. | Videla, S. | Argyriou, A. | +13

6

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

enthalten in: Neurotherapeutics | 2017

von Bruna, J. | Videla, S. | Argyriou, A. | +13

7

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

enthalten in: Neurotherapeutics | 2017

von Bruna, J. | Videla, S. | Argyriou, A. | +13

1
[1]